Multicenter, double-blind, placebo-controlled study of mecamylamine monotherapy for tourette's disorder

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 40, Issue 9, 2001, Pages 1103-1110

  Silver, Archie A ^a,b,e   Shytle, R Douglas ^a,d   Sheehan, Kathy H ^a,c   Sheehan, David V ^a,c   Ramos, Amaya ^a,b   Sanberg, Paul R ^a,d  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b Center of Infant and Child Development   (United States)

^c Department of Psychiatry and Behavioral Medicine

^d Center for Aging and Brain Repair   (United States)

^e UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Children; Mecamylamine; Mood; Nicotinic antagonist; Tourette's disorder

Indexed keywords

MECAMYLAMINE; PLACEBO;

ADOLESCENT; AFFECTIVE NEUROSIS; ARTICLE; BEHAVIOR DISORDER; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; GILLES DE LA TOURETTE SYNDROME; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MOOD; MULTICENTER STUDY; OUTCOMES RESEARCH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCHOOL CHILD; TACHYCARDIA;

EID: 0034870736     PISSN: 08908567     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004583-200109000-00020     Document Type: Article

References (46)

1. 3H]Mecamylamine binding to rat brain membranes: Studies with mecamylamine and nicotine analogues
2. Rage attacks in children and adolescents with Tourette's disorder: A pilot study
3. Future therapies of Tourette syndrome
4. Distinguishing illness severity from tic severity in children and adolescents with Tourette's disorder
5. Behavioral and emotional aspects of Tourette syndrome
6. Long-term ethanol and nicotine treatment elicit tolerance to ethanol
7. Differential effects of transdermal nicotine patch on the symptoms of Tourette's syndrome
8. Differential effects of transdermal nicotine on microstructured analyses of tics in Tourette's syndrome: An open study
9. Longlasting improvement of Tourette's syndrome with transdermal nicotine
10. ECG changes during haloperidol and pimozide treatment of Tourette's disorder
11. Clonidine and clonazepam in Tourette syndrome
12. Normative data on revised Conners Parent and Teacher Rating Scales
13. Guanfacine and secondary mania in children
14. Acute effects of nicotine on prolactin release in the rat: Agonist and antagonist effects of a single injection of nicotine
15. Clonidine treatment of Gilles de la Tourette's syndrome
16. The Yale Global Tic Severity Scale: Initial testing of a clinician-rated scale of tic severity
17. Mutually potentiating effects of mecamylamine and haloperidol in producing catalepsy in rats
18. Regulation by nicotine of its own receptors
19. Central actions of nicotine antagonists
20. The effects of nicotine plus haloperidol compared to nicotine only and placebo nicotine only in reducing tic severity and frequency in Tourette's disorder
21. Evidence for the nicotinic cholinergic hypothesis of cannabinoid action within the central nervous system: Extrapyramidal motor behaviors
22. Associated psychopathology in children with both ADHD and chronic tic disorder
23. Studies in the classification of affective disorders: The relationship between anxiety states and depressive illnesses, I
24. Nicotine potentiates the effects of haloperidol in animals and in patients with Tourette syndrome
25. Treatment of Tourette's syndrome with mecamylamine
26. Nicotine for the treatment of Tourette's syndrome
27. Tourette syndrome: A follow-up study
28. Guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder: A placebo-controlled study
29. Controlled study of haloperidol, pimozide, and placebo for the treatment of Gilles de la Tourette's syndrome
30. Development of the Tourette Disorder Scale (TODS)
31. The measurement of disability
32. The Mini-International Neuropsychiatric Interview (MINI): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10
33. Transdermal nicotine for Tourette's syndrome
34. Clinical assessment of motor abnormalities in Tourette's syndrome
35. Comorbid bipolar disorder in Tourette syndrome responds to nicotinic receptor antagonist, mecamylamine (Inversine®)
36. Causes of haloperidol discontinuation in patients with Tourette's disorder: Management and alternatives
37. Case study: Long-term potentiation of neuroleptics with transdermal nicotine in Tourette's syndrome
38. Clinical experience with transdermal nicotine patch in Tourette's syndrome
39. Mecamylamine in Tourette's syndrome: A two-year retrospective case
40. Transdermal nicotine and haloperidol in Tourette syndrome: A double-blind placebo controlled study
41. Development of behavioral and emotional problems in Tourette syndrome
42. Disentangling the overlap between Tourette's disorder and ADHD
43. Ganglionic blocking properties of 3-methylaminoisocamphane hydrochloride (mecamylamine): A secondary amine